NFX — Nuformix Income Statement
0.000.00%
Last trade - 00:00- £2.42m
- £2.40m
Annual income statement for Nuformix, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 18 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.535 | 0.196 | 0.05 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.201 | 0.133 | 0.048 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.45 | 1.57 | 1.32 | 0.928 | 3.65 |
| Operating Profit | -0.914 | -1.37 | -1.27 | -0.928 | -3.65 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.93 | -1.38 | -1.27 | -0.928 | -3.65 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.756 | -1.25 | -1.11 | -0.859 | -3.64 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.756 | -1.25 | -1.11 | -0.859 | -3.64 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.756 | -1.25 | -1.11 | -0.859 | -3.64 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.002 | -0.002 | -0.001 | -0.002 |
| Dividends per Share |